Light-Activated gel shows promise against rare skin cancer
Disease control
Recruiting now
This study tests a gel called HyBryte, which is activated by visible light, to treat a rare type of skin lymphoma (CTCL). About 80 adults with early-stage disease will apply the gel to their skin lesions and then receive light treatment. The goal is to see if the gel can shrink o…
Phase: PHASE3 • Sponsor: Soligenix • Aim: Disease control
Last updated May 11, 2026 20:40 UTC